16 / 70
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 5, September/October 2016
286
AFRICA
in Communities (ARIC) study.
Eur Heart J
2012;
33
: 183–190. doi:
10.1093/eurheartj/ehr192. PMID: 21666250.
6.
Neuschwander-Tetri BA. Nonalcoholic steatohepatitis and the meta-
bolic syndrome.
Am J Med Sci
2005;
330
: 326–335. PMID: 16355018.
7.
Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased
risk of cardiovascular disease.
Atherosclerosis
2007;
191
: 235–240.
PMID: 16970951.
8.
Ozturk K, Uygun A, Guler AK, Demirci H, Ozdemir C, Cakir M,
et
al
. Nonalcoholic fatty liver disease is an independent risk factor for
atherosclerosis in young adult men.
Atherosclerosis
2015;
240
: 380–386.
doi: 10.1016/j.atherosclerosis. PMID: 25875390
9.
Ryoo JH, HamWT, Choi JM, Kang MA, An SH, Lee JK,
et al
. Clinical
significance of non-alcoholic fatty liver disease as a risk factor for
prehypertension.
J Korean Med Sci
2014;
29
: 973–979. doi: 10.3346/
jkms.2014.29.7.973. PMID: 25045230.
10. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K,
et
al
. The diagnosis and management of non-alcoholic fatty liver disease:
practice guideline by the American Association for the Study of Liver
Diseases, American College of Gastroenterology, and the American
Gastroenterological Association.
Hepatology
2012;
55
: 2005–2023. doi:
10.1002/hep.25762. PMID: 22488764.
11. Vernon G, Baranova A, Younossi ZM. Systematic review: the epide-
miology and natural history of non-alcoholic fatty liver disease and
non-alcoholic steatohepatitis in adults.
Aliment Pharmacol Ther
2011;
34
: 274–285. doi: 10.1111/j.1365-2036.2011.04724.x. PMID: 21623852.
12. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK.
NAFLD as a risk factor for the development of diabetes and the meta-
bolic syndrome: an eleven-year follow-up study.
Am J Gastroenterol
2009; 104(4): 861–867. doi: 10.1038/ajg.2009.67. PMID: 19293782.
13. Ravussin E, Swinburn BA. Pathophysiology of obesity.
Lancet
1992;
340
: 404–408. PMID: 1353565.
14. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T,
et al
. Carotid intima-media thickness and presence or absence of
plaque improves prediction of coronary heart disease risk: the ARIC
(Atherosclerosis Risk In Communities) study.
J Am Coll Cardiol
2010;
55
: 1600–1607. doi: 10.1016/j.jacc.2009.11.075. PMID: 20378078.
15. Mohammadi A, Bazazi A, Ghasemi-Rad M. Evaluation of atheroscle-
rotic findings in patients with nonalcoholic fatty liver disease.
Int J Gen
Med
2011;
4
: 717–722. doi: 10.2147/IJGM.S25753. PMID: 22114515.
16. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histo-
gram technique that compares liver and renal cortical echo amplitudes.
J Clin Ultrasound
1996;
24
: 25–29. PMID: 8655663.
17. Sinning C, Wild PS, Echevarria FM, Wilde S, Schnabel R, Lubos E,
et
al.
Sex differences in early carotid atherosclerosis (from the community-
based Gutenberg-Heart Study).
Am J Cardiol
2011;
107
: 1841–1847. doi:
10.1016/j.amjcard.2011.02.318. PMID: 21481827.
18. Tan TY, Lu CH, Lin TK, Liou CW, Chuang YC, Schminke U. Factors
associated with gender difference in the intima–media thickness of the
common carotid artery.
Clin Radiol
2009;
64
: 1097–1103. doi: 10.1016/j.
crad.2009.06.009. PMID: 19822243.
19. Bae JH, Seung KB, Jung HO, Kim KY, Yoo KD, Kim CM,
et
al
. Analysis of Korean carotid intima–media thickness in Korean
healthy subjects and patients with risk factors: Korea Multi-Center
Epidemiological Study.
Korean Circ J
2005;
35
: 513–524.
20. Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic
fatty liver disease.
World J hepatol
2014;
6
: 274–283. doi: 10.4254/wjh.
v6.i5.274. PMID: 24868321.
21. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo
RA. Abdominal fat distribution and peripheral and hepatic insulin
resistance in type 2 diabetes mellitus.
Am J Physiol Endocrinol Metab
2002;
283
: E1135–1143. PMID: 12424102.
22. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist
gradually clears. J
Hepatol
2008;
48
Suppl 1: S104–112. doi: 10.1016/j.
jhep.2008.01.009. PMID: 18304679.
23. Lakatta EG. Arterial and cardiac aging: major shareholders in cardio-
vascular disease enterprises: Part III: cellular and molecular clues
to heart and arterial aging.
Circulation
2003;
107
: 490–497. PMID:
12551876.
24. Stensland-Bugge E, Bonaa KH, Joakimsen O, Njolstad I. Sex differenc-
es in the relationship of risk factors to subclinical carotid atherosclerosis
measured 15 years later : the Tromso study.
Stroke
2000;
31
: 574–581.
PMID: 10700488.
25. Lawlor DA, EbrahimS, Whincup P, Sterne J, Papacosta O, Wannamethee
G,
et al
. Sex differences in body fat distribution and carotid intima media
thickness: cross sectional survey using data from the British Regional
Heart study.
J Epidemiol Community Health
2004;
58
: 700–704. PMID:
15252075.
26. Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM,
et
al
. Gender and menopause impact severity of fibrosis among patients
with nonalcoholic steatohepatitis.
Hepatology
2014;
59
: 1406–1414. doi:
10.1002/hep.26761. PMID: 24123276.
27. Hewitt KN, Pratis K, Jones ME, Simpson ER. Estrogen replacement
reverses the hepatic steatosis phenotype in the male aromatase knockout
mouse.
Endocrinology
2004;
145
: 1842–1848. PMID: 14684602.
28. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto
J,
et al.
Aromatase-deficient (ArKO) mice have a phenotype of increased
adiposity.
Proc Natl Acad Sci USA
2000;
97
: 12735–12740. PMID:
11070087.
29. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O.
Alteration of reproductive function but not prenatal sexual development
after insertional disruption of the mouse estrogen receptor gene.
Proc
Natl Acad Sci USA
1993;
90
: 11162–11166. PMID: 8248223.
30. Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, Davis BJ,
et al.
Postnatal sex reversal of the ovaries in mice lacking estrogen receptors
alpha and beta.
Science
1999;
286
: 2328–2331. PMID: 10600740.
31. Mendelsohn ME, Karas RH. The protective effects of estrogen on the
cardiovascular system.
N Engl J Med
1999;
340
: 1801–1811. PMID:
10362825.